Smith & Nephew
Corporate

Select your country

Smith & Nephew

Advanced Search
  • Home
  • About Us
  • Innovation & Products
  • Sustainability
  • Investor Centre
  • News & Media
  • Careers
  • Home
  • Sustainability
  • Policies and Principles
  • Economic Contribution Principles
  • Healthcare Economics
  • Advanced Wound Management
  • Home >
  • Sustainability >
  • Policies and Principles >
  • Economic Contribution Principles >
  • Healthcare Economics >
  • Advanced Wound Management
  • Orthopaedics
  • Endoscopy
  • Advanced Wound Management
    • PROFORE
    • VERSAJET
  • Biologics and Clinical Therapies
  • Contact
  • Print
  • Forward

Email this page

close
  1. Mandatory fields are marked with an asterisk [*].

    Tell us who you want to send your mail to Fill in your email details

    Note: Smith & Nephew does not collect or make use of the email addresses or names provided here. They are only used to show the recipient who has sent the message.

    Change your message if you want Change the message if you want to

    1. <recipient name> <address>
    2. <sender name> <address>
    3. <sender name> is sending you a link

    4. <sender name>

    Visitor verfication

Email sent successfully
Error: Check all fields are valid. Exclude special characters from Comments field
Smith
Nephew

Advanced Wound Management

AdvancedWoundManagement_Typicalcostofhealingawoundbreakdownbytypeofcost

Due to the nature of the Advanced Wound Management business more work has been carried out in the area of health economics than our other businesses. Advanced wound products are typically more expensive than traditional products, but it is important to focus on the total cost of patient care, rather than on the costs of individual components of care. As a result it is essential to look at the overall wound healing programme from initial diagnosis to wound closure to make a strong case for application of our advanced wound healing range.

In wound care the cost of products typically represent no more than 10-15% of total treatment cost. The dominant cost is the cost of labour. Thus, the practical application of our strategic aim requires that we seek solutions which reduce overall costs by substituting the cost of wound care products for the cost of medical and nursing time. In the new paradigm, the cost of products will come to account for a higher share of the total cost of treating patients.

Recent case studies by product:

  • VERSAJET
  • PROFORE
  • ◊ Trademark of Smith & Nephew
  • Accessibility
  • Terms of Use
  • Copyright & Disclaimer